Category Archives: Coalition News

REQUEST FOR RELEASE OF SENATE FINANCE COMMITTEE INVESTIGATION

On September 16, 2015 a letter from FED UP! Coalition partners was sent to the current chairman and ranking member of the Senate Finance Committee seeking public release of their findings.  Click here to read more about the letter and how you can contact your Senators.

Fed Up! has received a lot of great coverage for sending this letter. Click here to read Med Page Today’s article.

FED UP! Coalition comments on draft National Pain Strategy

Screen Shot 2015-05-29 at 11.08.23 AM

The FED UP! Coalition has submitted comments to Dr. Linda Porter at the National Institutes of Health on the draft National Pain Strategy. These comments state that “the draft National Pain Strategy contains language that suggests a gross misunderstanding of our opioid crisis and the interventions required to reduce harm to pain patients caused by opioid overprescribing.”  The letter contains recommendations for significant revisions.  Read Fed Up comments on the National Pain Strategy.

The FED UP! Coalition had a booth in the exhibit hall at the National Prescription Drug Abuse Summit

Bill April Karen Andrew Judy Dan at Drug Summit

Volunteers for FED UP! at the booth in Atlanta: Bill Rummler, April Rovero, Karen Carlini, Andrew Kolodny MD, Judy Rummler and Dan Busch MD.

The FED UP! Coalition had a booth in the exhibit hall at the National Prescription Drug Abuse Summit April 6-9th in Atlanta.  There was great interest from the 1400 attendees as volunteers distributed information about the 2015 FED UP! Rally at the Lincoln Memorial on October 3rd and the local rallies being planned around the country on August 31st, International Overdose Awareness Day.

Below: Bill Rummler with Patrick Kennedy

with Patrick Kennedy

BREAKING NEWS – February 2015

Last September, FED UP! sent a letter to Sylvia Burwell, the U.S. Secretary of Health and Human Services, asking her to pursue leadership change at FDA. Our letter was prompted by FDA’s approval of a steady stream of new opioids, concerns about serious conflicts of interest in the analgesic division and FDA’s failure to enforce the Food, Drug, and Cosmetic Act (FD&C), a law that prohibits marketing of drugs for conditions where risks of use may outweigh potential benefits. If FDA were properly enforcing the FD&C, drug companies would not be allowed to promote long-term use of opioids for common problems like low back pain.

We were very pleased to learn yesterday that Dr. Margaret Hamburg, the Commissioner of the FDA, submitted her resignation. We do not know if Secretary Burwell requested her resignation or if it was voluntary. Either way, this change makes us hopeful. Under new leadership at FDA, we stand a chance of finally seeing public health prioritized over the interests of pharmaceutical companies. But we also know that this will not happen without continued pressure from advocates like you.

We also learned this week that President Obama earmarked $100 million in his 2016 budget for the opioid crisis. We are pleased that for the first time his administration is asking for funds to address the opioid crisis but unfortunately this funding is very little, very late and is unlikely to stem the rising tide of opioid overdose deaths. We are especially disturbed that only a small portion of the proposed $100 million is for treatment of opioid addiction. Until treatment is easier to access than painkillers and heroin we believe opioid overdose deaths will remain at historically high levels and heroin will continue flooding into our communities.